ArticleFuture oncology (London, England)2024

LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma.

Jong-Mu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.